AC Immune SA (ACIU)
2.46
-0.04
(-1.60%)
USD |
NASDAQ |
Oct 12, 14:57
AC Immune Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -20.87M |
| September 30, 2025 | -24.41M |
| June 30, 2025 | -21.18M |
| March 31, 2025 | -21.33M |
| December 31, 2024 | 5.805M |
| September 30, 2024 | -12.94M |
| June 30, 2024 | 80.63M |
| March 31, 2024 | 0.8864M |
| December 31, 2023 | -18.22M |
| September 30, 2023 | -15.98M |
| June 30, 2023 | -16.42M |
| March 31, 2023 | -18.38M |
| December 31, 2022 | -18.27M |
| September 30, 2022 | -14.06M |
| June 30, 2022 | -19.64M |
| March 31, 2022 | -25.64M |
| December 31, 2021 | -19.91M |
| September 30, 2021 | -16.00M |
| June 30, 2021 | -18.19M |
| March 31, 2021 | -20.01M |
| December 31, 2020 | -23.18M |
| Date | Value |
|---|---|
| September 30, 2020 | -18.46M |
| June 30, 2020 | -15.87M |
| March 31, 2020 | -10.22M |
| December 31, 2019 | -13.73M |
| September 30, 2019 | 17.63M |
| June 30, 2019 | -15.71M |
| March 31, 2019 | 65.67M |
| December 31, 2018 | -11.63M |
| September 30, 2018 | -12.21M |
| June 30, 2018 | -7.076M |
| March 31, 2018 | -15.21M |
| December 31, 2017 | 7.207M |
| September 30, 2017 | -8.617M |
| June 30, 2017 | -10.36M |
| March 31, 2017 | -12.44M |
| December 31, 2016 | -7.211M |
| September 30, 2016 | 8.413M |
| June 30, 2016 | 0.2037M |
| March 31, 2016 | -7.944M |
| December 31, 2015 | -6.976M |
| September 30, 2015 | 34.31M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Precigen, Inc. | -18.20M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| Aldeyra Therapeutics, Inc. | -4.612M |
| BeOne Medicines Ltd. | 436.10M |